11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Celery extract inhibits mouse CYP2A5 and human CYP2A6 activities via different mechanisms

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Human cytochrome P450 (CYP) 2A6 participates in the metabolism of nicotine and precarcinogens, thus the deliberate inhibition of CYP2A6 may reduce cigarette consumption and therefore reduce the risk of developing the types of cancer associated with smoking. The inhibitory effects and mechanisms of celery ( Apium graveolens) extract on mouse CYP2A5 and human CYP2A6 activity remain unclear. These effects were investigated in mouse and human liver microsomes using coumarin 7-hydroxylation in a probe reaction. Celery extract reduced CYP2A5 and CYP2A6 activities in vitro in a dose-dependent manner. In vivo experiments also showed that celery extract markedly decreased CYP2A5 activity. The inhibition of celery extract on CYP2A5 was time- and nicotinamide adenine dinucleotide phosphate (NADPH)-independent, and was markedly reduced by ultracentrifugation. Additionally, the inhibition of celery extract on CYP2A6 was time and NADPH-dependent. Levels of inhibition were characterized by a K i, the measure of the tightness of bonds between the enzyme and its inhibitor, of 266.4 µg/ml for CYP2A5, and a K i of 1,018 µg/ml and K inact of 0.3/min for CYP2A6. K inact is the maximal rate of enzyme inactivation at a saturating concentration of inhibitor. The coumarin derivative 5-methoxypsoralen present in celery extract did not solely to the inhibition of CYP2A5/6 activity. In conclusion, celery extract inhibited the levels of mouse CYP2A5 and human CYP2A6 activity via different mechanisms: Mixed competitive inhibition for CYP2A5 and mechanism-based inhibition for CYP2A6.

          Related collections

          Author and article information

          Journal
          Oncol Lett
          Oncol Lett
          OL
          Oncology Letters
          D.A. Spandidos
          1792-1074
          1792-1082
          December 2016
          25 October 2016
          25 October 2016
          : 12
          : 6
          : 5309-5314
          Affiliations
          Institute of Life Sciences, Chongqing Medical University, Chongqing 400016, P.R. China
          Author notes
          Correspondence to: Professor Chao Yu, Institute of Life Sciences, Chongqing Medical University, 1 Yixueyuan Road, Yuzhong, Chongqing 400016, P.R. China, E-mail: yuchaom@ 123456163.com
          Article
          PMC5228217 PMC5228217 5228217 OL-0-0-5317
          10.3892/ol.2016.5317
          5228217
          28101244
          a4c76fd3-1c6b-45d2-9ce2-a1b2bdecb51b
          Copyright © 2016, Spandidos Publications
          History
          : 29 July 2015
          : 13 September 2016
          Categories
          Articles

          mechanism-based inhibition, Apium graveolens ,coumarin 7-hydroxylase

          Comments

          Comment on this article